PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,620.00
+16.00 (1.00%)
At close: Oct 2, 2025
PeopleBio Revenue
PeopleBio had revenue of 732.69M KRW in the quarter ending June 30, 2025, a decrease of -46.41%. This brings the company's revenue in the last twelve months to 3.13B, down -29.76% year-over-year. In the year 2024, PeopleBio had annual revenue of 3.73B, down -16.20%.
Revenue (ttm)
3.13B
Revenue Growth
-29.76%
P/S Ratio
10.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | -721.35M | -16.20% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | 507.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Doosan Enerbility | 16.30T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |